MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Clinical and Genetic Profile of Spinocerebellar Ataxias in a Tunisian Cohort

    M S. Majoul, R. Zouari, A. Kalfat, R. Amouri, D. Ben Mohamed, M Z. Saied, F. Nabli, S. Ben Sassi (Tunis, Tunisia)

    Objective: Our aim was to determine the clinical, genetic and radiological characteristics of spinocerebellar ataxias (SCA) in a Tunisian cohort. Background: SCA is a heterogenous…
  • 2024 International Congress

    Prevalence of Heterozygous ATP7B Mutation in Patients with Movement Symptoms

    Y. Kim, D. Park, J. Yoon (Suwon, Republic of Korea)

    Objective: The objective of our study is to elucidate the prevalence of heterozygous ATP7B mutation in patients with movement symptoms. We aim to determine whether…
  • 2024 International Congress

    When the Nephrologist calls… Ataxia, Seizures, and Hypokalemia – EAST syndrome and KCJN10 gene mutation

    P. Fraiman, T. Coradine, M. Soares, I. Raslan, L. Gouvêa, L. Corazza, B. Massuyama, T. Silva, J. Pedroso, O. Barsottini (São Paulo, Brazil)

    Objective: To present a case study of a 32-year-old woman with pathogenic variant in KCJN10 gene exhibiting ataxia and dystonic posturing with recurrent severe hypokalemia…
  • 2024 International Congress

    Phenotypic spectrum and natural history of POLR3A-associated spastic ataxia

    E. Jung, J. Infante, S. Satolli, F. Santorelli, M. Minnerop, S. Klebe, B. Warrenburg, J. Muñoz, A. Fellner, J. de Winter, A. O'Connor, J. Baets, S. Murphy, M. Ruiz Sales, A. Pujol Onofre, L. Ruggiero, G. Coarelli, A. Dürr, X. Kobeleva, C. Stendel, T. Klopstock, F. Nicita, E. Bertini, Q. Thomas, Y. Goldberg, E. Kogan, L. Basel-Salmon, A. Lossos, Z. Argov, A. de Munain, L. Schöls, R. Schüle (Heidelberg, Germany)

    Objective: To foster trial-readiness, we delineate the full phenotypic spectrum and provide piloting longitudinal natural progression data of POLR3A-associated spastic ataxia in a large international cohort.…
  • 2024 International Congress

    The first Indian patient with Hereditary Spastic Paraparesis type 42 due to a de novo SLC33A1 variant

    A. Agarwal, P. Sharma, D. Garg, A. Garg, M. Faruq, A. Srivastava (New Delhi, India)

    Objective: Hereditary Spastic Paraparesis (HSP) 42 is an autosomal dominant HSP caused by pathogenic mutations in the SLC33A1 gene. This subtype has been reported from a…
  • 2024 International Congress

    Distinguishing Parkinson’s disease from atypical Parkinsonian syndrome using multistage deep learning based on dopamine transporter imaging

    JS. Park, JY. Gwak (Busan, Republic of Korea)

    Objective: We made the diagnostic model using a deep learning algorithm based on dopamine transporterWe made the diagnostic model using a deep learning algorithm based…
  • 2024 International Congress

    The novel Gait Cycle Detection Network (GCDN) for Video based gait Analysis based on single 2D RGB video

    DY. Kim, R. Yu, YS. Lee, YK. Kim, JH. Shin, C. Hansen, W. Maetzler (Suwon, Republic of Korea)

    Objective: The goal of this work is to train a network that detects a gait cycle precisely to improve the accuracy of a video-based gait…
  • 2024 International Congress

    Clinical and Imaging Changes in Parkinson’s Disease Patients Under Spinal Cord Stimulation: A Double Blinded Analysis

    R. Carra, L. Garcia, J. Menezes, T. Capato, E. Barbosa, K. Duarte, M. Teixeira, R. Cury (Sao Paulo, Brazil)

    Objective: Evaluate clinical and biomarker changes from spinal cord stimulation (SCS) in Parkinsons Disease (PD) under sham controlled randomized evaluation. Background: SCS has been proposed…
  • 2024 International Congress

    Impact of Altered Cerebrovascular Reactivity on Midbrain Degeneration, Perfusion and White Matter

    N. Hoffman, S. Nitschke, K. Julio, N. Shaff, A. Dodd, G. Suarez Cedeno, A. Deligtisch, D. Sugar, E. Erhardt, H. Lin, A. Vakhtin, H. Van-Der-Horn, S. Pirio Richardson, A. Mayer, S. Ryman (Albuquerque, USA)

    Objective: To evaluate whether altered cerebrovascular reactivity contributes to midbrain degeneration, perfusion abnormalities, or white matter disease in patients with Parkinson’s disease (PD). Background: Cerebrovascular…
  • 2024 International Congress

    Effects of ATH434, a Clinical-Phase Small Molecule with Moderate Affinity for Iron, in a Parkinson’s Disease Model in Macaques

    M. Bradbury, M. Aumann, D. Claassen, D. Finkelstein (Newark, USA)

    Objective: (1) Determine whether oral ATH434 improves motor performance in a non-human primate hemiparkinasonian model when administered after symptom onset. (2) Relate observations to changes…
  • « Previous Page
  • 1
  • …
  • 457
  • 458
  • 459
  • 460
  • 461
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley